Valuation : DocMorris AG

Market Cap 51Cr 63Cr 54Cr 46Cr 86Cr 5.94TCr 87Cr 600.61Cr 232.37Cr 3.04TCr 235.32Cr 230.18Cr 9.66TCr P/E 2026 *
-6.22x
P/E 2027 * -14.3x
Enterprise Value 71Cr 88Cr 75Cr 65Cr 120.79Cr 8.31TCr 121.41Cr 840.33Cr 325.12Cr 4.25TCr 329.25Cr 322.06Cr 14TCr EV / Sales 2026 *
0.56x
EV / Sales 2027 * 0.53x
Free-Float
65.15%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Director/Board Member 53 23/05/2019
Chairman 68 28/04/2022
Director/Board Member 60 12/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 63Cr
-3.66%-4.70%-47.45%-18.19% 1.49TCr
-2.84%-1.52%-21.50%-11.52% 664.19Cr
-2.87%-0.16%-57.28%-35.52% 647.3Cr
-0.79%-1.31%-13.52%-20.93% 408.97Cr
-0.81%-0.49%-19.66%-38.07% 321.62Cr
-0.92%-0.92%+3.05%-27.62% 309.5Cr
-0.12%-5.33%-45.80%-26.74% 285.89Cr
+4.12%+9.21%+47.14% - 268.89Cr
-2.39%-0.41%-16.65%-7.31% 250.21Cr
Average -9.84%+1.42%-19.08%-23.24% 516.14Cr
Weighted average by Cap. -3.21%+1.00%-29.60%-22.06%

Financials

2026 *2027 *
Net sales 126.14Cr 155.94Cr 134.08Cr 115.11Cr 214.82Cr 15TCr 215.93Cr 1.49TCr 578.22Cr 7.56TCr 585.57Cr 572.78Cr 24TCr 140.51Cr 173.71Cr 149.35Cr 128.23Cr 239.29Cr 16TCr 240.53Cr 1.66TCr 644.1Cr 8.42TCr 652.28Cr 638.04Cr 27TCr
Net income -8.59Cr -11Cr -9.13Cr -7.84Cr -15Cr -1.01TCr -15Cr -101.78Cr -39Cr -514.61Cr -40Cr -39Cr -1.64TCr -3.89Cr -4.81Cr -4.14Cr -3.55Cr -6.63Cr -456.36Cr -6.67Cr -46Cr -18Cr -233.26Cr -18Cr -18Cr -742.28Cr
Net Debt 20Cr 25Cr 22Cr 18Cr 34Cr 2.37TCr 35Cr 239.72Cr 93Cr 1.21TCr 94Cr 92Cr 3.86TCr 23Cr 29Cr 25Cr 21Cr 40Cr 2.72TCr 40Cr 275.03Cr 106.41Cr 1.39TCr 107.76Cr 105.41Cr 4.43TCr
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
10.04CHF
Average target price
11.29CHF
Spread / Average Target
+12.49%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!